Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.58 |
| ▸ | ALPI | P09923 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | XIAP | P98170 | 1/20 | 0.58 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.58 |
| ▸ | NOS3 | P29474 | 3/20 | 0.57 |
| ▸ | NOS1 | P29475 | 3/20 | 0.57 |
| ▸ | NOS2 | P35228 | 3/20 | 0.57 |
| ▸ | PPARG | P37231 | 1/20 | 0.53 |
| ▸ | PPARA | Q07869 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | BLM | P54132 | 2/20 | 0.51 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.51 |
| ▸ | MPO | P05164 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL35491891 | 1.00 | PKM (0.58) | PKMALPIPTGS1XIAPSLC7A5 | |
| SCHEMBL43977 | 1.00 | PKM (0.58) | PKMALPIPTGS1XIAPSLC7A5 | |
| SCHEMBL29351556 | 1.00 | PKM (0.58) | PKMALPIPTGS1XIAPSLC7A5 | |
| SCHEMBL43976 | 1.00 | PKM (0.58) | PKMALPIPTGS1XIAPSLC7A5 | |
| Hydrochloric Acid SCHEMBL21904241 | 0.98 | PKM (0.56) | PKMALPIPTGS1XIAPSLC7A5 | |
| Hydrochloric Acid SCHEMBL1514957 | 0.98 | PKM (0.56) | PKMALPIPTGS1XIAPSLC7A5 | |
| Hydrochloric Acid SCHEMBL27479478 | 0.98 | PKM (0.56) | PKMALPIPTGS1XIAPSLC7A5 | |
| Methyl Alcohol SCHEMBL28880032 | 0.96 | NOS3 (0.56) | PKMALPIPTGS1XIAPSLC7A5 | |
| Methyl Alcohol SCHEMBL29067173 | 0.95 | NOS3 (0.55) | PKMALPIPTGS1XIAPSLC7A5 | |
| SCHEMBL13971424 | 0.86 | SLC7A5 (0.69) | PKMALPIPTGS1XIAPSLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 468 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4696699-A1 | ? OPIOID RECEPTOR AGONIST AND USE THEREOF | Chengdu Aoda Biotechnology Co., Ltd. (CN) | 2026-02-18 | — | — | EP | claimed |
| EP-4696700-A1 | LONG-ACTING K-OPIOID RECEPTOR AGONIST | Chengdu Aoda Biotechnology Co., Ltd (CN) | 2026-02-18 | — | — | EP | claimed |
| CN-119899240-A | Kappa opioid receptor agonist and application thereof | 成都奥达生物科技有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-119390765-A | Kappa opioid receptor agonist and application thereof | 成都奥达生物科技有限公司 | 2025-02-07 | — | — | CN | claimed |
| WO-2024212865-A1 | κ OPIOID RECEPTOR AGONIST AND USE THEREOF | 成都奥达生物科技有限公司 | 2024-10-17 | — | — | WO | claimed |
| WO-2024212866-A1 | LONG-ACTING K-OPIOID RECEPTOR AGONIST | 成都奥达生物科技有限公司 | 2024-10-17 | — | — | WO | claimed |
| CN-118772231-A | Kappa opioid receptor agonist and application thereof | 成都奥达生物科技有限公司 | 2024-10-15 | — | — | CN | claimed |
| US-20240008483-A1 | COMPOSITION FOR MOLD REMEDIATION | MOLD GUARD INC. (CA) | 2024-01-11 | — | — | US | claimed |
| CN-116997648-A | Composition for mould repair | 霉菌防护有限公司 | 2023-11-03 | — | — | CN | claimed |
| EP-4244364-A1 | COMPOSITION FOR MOLD REMEDIATION | Mold Guard Inc. (CA) | 2023-09-20 | — | — | EP | claimed |
| US-10344054-B2 | Angiotensin-1-receptor antagonists | FERRING B.V. (NL) | 2019-07-09 | — | — | US | claimed |
| EP-3464324-A1 | ANGIOTENSIN-1-RECEPTOR ANTAGONISTS | Ferring B.V. (NL) | 2019-04-10 | — | — | EP | claimed |
| CN-109311942-A | Angiotensin-1 receptor antagonists | 辉凌公司 | 2019-02-05 | — | — | CN | claimed |
| CN-105866299-B | The non-targeted metabolism group sample pretreating method of plant based on GC-MS | 上海鹿明生物科技有限公司 | 2018-11-13 | — | — | CN | claimed |
| WO-2017207760-A1 | ANGIOTENSIN-1-RECEPTOR ANTAGONISTS | FERRING B.V. (NL) | 2017-12-07 | — | — | WO | claimed |
| US-20170349629-A1 | Angiotensin-1-Receptor Antagonists | FERRING B.V. (NL) | 2017-12-07 | — | — | US | claimed |
| US-9695191-B2 | Conformationally constrained, fully synthetic macrocyclic compounds | POLYPHOR AG (CH) | 2017-07-04 | — | — | US | claimed |
| CN-105866299-A | GC-MS-based plant non-targeted metabolomics sample pretreatment method | 上海青鹿投资有限公司 | 2016-08-17 | — | — | CN | claimed |
| EP-2462147-B1 | CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS | POLYPHOR AG (CH) | 2014-11-12 | — | — | EP | claimed |
| US-20120202821-A1 | CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS | POLYPHOR AG (CH) | 2012-08-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170349629-A1 | Angiotensin-1-Receptor Antagonists | AGTR1, AGTR2, REN | PKM 3664/4885ALPI 3555/4885PTGS1 122/4885 |
| US-20120202821-A1 | CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS | HTR2B, MC1R, HTR1A | PKM 2553/4885ALPI 2014/4885PTGS1 109/4885 |
| US-10344054-B2 | Angiotensin-1-receptor antagonists | AGTR1, AGTR2, AGT | PKM 3198/4885ALPI 3362/4885PTGS1 138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.